Significant Ownership of Point72 Asset Management, L.P.

Notable people
Steven A. Cohen
Signature - Title
/s/ Jason M. Colombo - Jason M. Colombo, Authorized Person
Location
Stamford, CT
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Point72 Asset Management, L.P..

Notify me when Point72 Asset Management, L.P. files a new Schedule 13D/G report.

⭐ Subscribe ⭐

Significant Ownership of Point72 Asset Management, L.P.

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
CCCC C4 Therapeutics, Inc. Common Stock, par value $0.0001 per share 9.9% $50,277,776 22,647,647 Point72 Asset Management, L.P. 17 Oct 2025
CYBN CYBIN INC. Common Shares, no par value 9.9% $37,759,482 +$28,298,275 6,410,778 +299% Point72 Asset Management, L.P. 30 Sep 2025
PTNT PALATIN TECHNOLOGIES INC Common Stock, par value $0.01 per share 9.9% $23,646,750 2,307,000 Point72 Asset Management, L.P. 12 Nov 2025
FGNX FG Nexus Inc. Common Stock, par value $0.001 per share 9.9% $23,560,000 +$3,092,250 4,000,000 +15% Point72 Asset Management, L.P. 30 Sep 2025
IBIO iBio, Inc. Common Stock, par value $0.001 per share 9.9% $11,288,403 14,289,118 Point72 Asset Management, L.P. 22 Aug 2025
XLO Xilio Therapeutics, Inc. Common Stock, par value $0.0001 per share 9.9% $6,752,000 +$3,376,000 8,000,000 +100% Point72 Asset Management, L.P. 30 Sep 2025
IVVD Invivyd, Inc. Common Stock, par value $0.0001 per share 9.7% $22,409,727 +$4,006,213 20,372,479 +22% Point72 Asset Management, L.P. 30 Sep 2025
PRAX Praxis Precision Medicines, Inc. Common Stock, par value $0.0001 per share 9.6% $109,866,297 +$28,721,283 2,072,949 +35% Steven A. Cohen 30 Sep 2025
TNXP Tonix Pharmaceuticals Holding Corp. Common Stock, par value $0.001 per share 9.2% $19,884,434 1,235,058 Point72 Asset Management, L.P. 29 Dec 2025
Aptevo Therapeutics Inc. Common Stock, par value $0.001 per share 9.1% 299,944 Point72 Asset Management, L.P. 16 Sep 2025
KRRO Korro Bio, Inc. Common Stock, par value $0.001 per share 8.7% $19,336,141 816,905 Steven A. Cohen 30 Jun 2025
1RT Acquisition Corp. Class A Ordinary Shares, par value $0.0001 per share 8.7% 1,500,000 Point72 Asset Management, L.P. 03 Jul 2025
AVTX Avalo Therapeutics, Inc. Common Stock, par value $0.001 per share 8% $13,396,124 +$5,914,611 1,053,983 +79% Point72 Asset Management, L.P. 30 Sep 2025
RLAY Relay Therapeutics, Inc. Common Stock, par value $0.001 per share 7.8% $47,463,335 +$13,242,749 13,445,704 +39% Point72 Asset Management, L.P. 30 Jun 2025
ANAB ANAPTYSBIO, INC Common Stock, par value $0.001 per share 7.7% $40,664,913 +$11,624,056 2,368,370 +40% Point72 Asset Management, L.P. 31 Mar 2025
ZEPP Zepp Health Corp Class A Ordinary Shares, par value $0.0001 per share 7.6% $401,811,426 +$105,513,012 8,777,008 +36% Point72 Asset Management, L.P. 30 Sep 2025
TENX TENAX THERAPEUTICS, INC. Common Stock, par value $0.0001 per share 7.4% $2,037,798 339,633 Point72 Asset Management, L.P. 22 Oct 2025
ADCT ADC Therapeutics SA Common Shares, par value CHF 0.08 per share 7% $10,494,110 7,831,425 Point72 Asset Management, L.P. 16 Jun 2025
ANRO Alto Neuroscience, Inc. Common Stock, par value $0.0001 per share 7% $4,063,680 -$962,973 1,907,831 -19% Steven A. Cohen 31 Mar 2025
CLDX Celldex Therapeutics, Inc. Common Stock, par value $0.001 per share 6.7% $84,421,804 4,464,400 Point72 Asset Management, L.P. 02 Jul 2025
PLRX PLIANT THERAPEUTICS, INC. Common Stock, par value $0.0001 per share 6.7% $6,617,728 4,085,017 Point72 Asset Management, L.P. 27 Aug 2025
GLTO Galecto, Inc. Common Stock, par value $0.00001 per share 6.3% $380,004 100,001 Point72 Asset Management, L.P. 12 Nov 2025
CDTX Cidara Therapeutics, Inc. Common Stock, par value $0.0001 per share 6.2% $151,115,887 +$4,801,311 1,578,069 +3.3% Point72 Asset Management, L.P. 30 Sep 2025
WWW WOLVERINE WORLD WIDE INC /DE/ Common Stock, par value $1 per share 6.2% $139,279,403 +$27,481,325 5,075,780 +25% Point72 Asset Management, L.P. 30 Sep 2025
ANGO ANGIODYNAMICS INC Common Stock, par value $0.01 per share 6.2% $28,588,375 +$4,905,719 2,559,389 +21% Point72 Asset Management, L.P. 30 Sep 2025
PALI PALISADE BIO, INC. Common Stock, par value $0.01 per share 6.2% $4,399,654 7,585,611 Point72 Asset Management, L.P. 06 Oct 2025
VSTM Verastem, Inc. Common Stock, par value $0.0001 per share 6.1% $24,904,606 3,338,419 Point72 Asset Management, L.P. 25 Jul 2025
CFLT Confluent, Inc. Class A Common Stock, par value $0.00001 per share 6% $347,129,897 +$60,803,978 17,531,813 +21% Point72 Asset Management, L.P. 30 Sep 2025
WOLFSPEED, INC. Common Stock, par value $0.00125 per share 6% 1,545,987 Steven A. Cohen 09 Oct 2025
IMNM Immunome Inc. Common Stock, par value $0.0001 per share 5.9% $34,698,481 4,887,110 Point72 Asset Management, L.P. 31 Jan 2025
PAGS PagSeguro Digital Ltd. Class A Common Shares, par value $0.000025 per share 5.7% $101,471,520 -$22,999,590 10,147,152 -18% Point72 Asset Management, L.P. 30 Sep 2025
MSGE Madison Square Garden Entertainment Corp. Class A Common Stock, par value $0.01 per share 5.5% $67,938,784 2,239,248 Point72 Asset Management, L.P. 31 Dec 2024
KOD Kodiak Sciences Inc. Common Stock, par value $0.0001 per share 5.5% $28,244,798 2,908,836 Point72 Asset Management, L.P. 15 Aug 2025
BRCB Black Rock Coffee Bar, Inc. Class A Common Stock, par value $0.00001 per share 5.4% $22,629,182 948,415 Steven A. Cohen 12 Nov 2025
IPSC Century Therapeutics, Inc. Common Stock, par value $0.0001 per share 5.4% $2,504,589 4,725,639 Point72 Asset Management, L.P. 23 Dec 2025
DNTH Dianthus Therapeutics, Inc. /DE/ Common Stock, par value $0.001 per share 5.3% $39,962,278 +$4,273,590 2,121,140 +12% Point72 Asset Management, L.P. 11 Sep 2025
DSGN Design Therapeutics, Inc. Common Stock, par value $0.0001 per share 5.2% $16,596,935 2,942,719 Point72 Asset Management, L.P. 27 Aug 2025
LION Lionsgate Studios Corp. Common Shares, no par value per share 5.1% $101,210,670 14,668,213 Point72 Asset Management, L.P. 31 Oct 2025
ORIC Oric Pharmaceuticals, Inc. Common Stock, par value $0.0001 per share 5.1% $45,161,021 4,401,659 Point72 Asset Management, L.P. 29 May 2025
OVID Ovid Therapeutics Inc. Common Stock, par value $0.001 per share 5.1% $11,099,895 6,727,209 Point72 Asset Management, L.P. 02 Jan 2026
BILL BILL Holdings, Inc. Common Stock, par value $0.00001 per share 5% $247,450,711 5,035,627 Point72 Asset Management, L.P. 21 Nov 2025
RUN Sunrun Inc. Common Stock, par value $0.0001 per share 5% $136,891,257 11,503,467 Point72 Asset Management, L.P. 26 Jun 2025
IDYA IDEAYA Biosciences, Inc. Common Stock, par value $0.0001 per share 5% $80,218,014 4,412,432 Point72 Asset Management, L.P. 06 Jun 2025
SNDX Syndax Pharmaceuticals Inc Common Stock, par value $0.0001 per share 5% $66,650,461 +$31,109,971 4,327,952 +88% Point72 Asset Management, L.P. 15 Aug 2025
LENZ LENZ Therapeutics, Inc. Common Stock, par value $0.00001 per share 4.8% $63,244,042 1,357,751 Steven A. Cohen 30 Sep 2025
REPL Replimune Group, Inc. Common Stock, par value $0.001 per share 4.7% $15,209,289 -$3,488,586 3,629,902 -19% Point72 Asset Management, L.P. 30 Sep 2025
LLYVA Liberty Media Corp Series A Liberty Live Common Stock, par value $0.01 per share 4.6% $77,719,964 1,164,693 Point72 Asset Management, L.P. 31 Dec 2024
VTYX Ventyx Biosciences, Inc. Common Stock, par value $0.0001 per share 4.5% $9,982,638 -$8,352,206 3,209,645 -46% Point72 Asset Management, L.P. 30 Sep 2025
RCUS Arcus Biosciences, Inc. Common Stock, par value $0.0001 per share 4.1% $58,921,714 -$20,381,232 4,332,479 -26% Point72 Asset Management, L.P. 30 Sep 2025
COGT Cogent Biosciences, Inc. Common Stock, par value $0.001 per share 4% $82,625,042 -$60,775,814 5,753,833 -42% Point72 Asset Management, L.P. 30 Sep 2025
ALTS ALT5 Sigma Corp Common Stock, par value $0.001 per share 4% 4,872,756 Point72 Asset Management, L.P. 11 Aug 2025
STNE StoneCo Ltd. Class A Common Shares, par value US$0.000079365 per share 3.9% $165,537,092 -$68,694,386 9,972,114 -29% Point72 Asset Management, L.P. 30 Jun 2025
BCYC BICYCLE THERAPEUTICS PLC Ordinary Shares, nominal value 0.01 GBP per share 3.9% $14,287,235 -$14,430,728 1,860,317 -50% Point72 Asset Management, L.P. 30 Jun 2025
TDOC Teladoc Health, Inc. Common Stock, par value $0.001 per share 3.3% $44,796,726 -$23,430,960 5,795,178 -34% Point72 Asset Management, L.P. 30 Sep 2025
ATYR aTYR PHARMA INC Common Stock, par value $0.001 per share 3.2% $8,109,259 2,845,354 Point72 Asset Management, L.P. 31 Mar 2025
PEPG PepGen Inc. Common Stock, par value $0.0001 per share 3% $10,167,217 -$2,992,506 2,067,432 -23% Point72 Asset Management, L.P. 30 Sep 2025
DRUG BRIGHT MINDS BIOSCIENCES INC. Common Shares, without par value 3% $4,876,267 135,189 Point72 Asset Management, L.P. 31 Dec 2024
MBLY Mobileye Global Inc. Class A Common Stock, par value $0.01 per share 2.8% $84,823,217 -$3,371,672 6,007,310 -3.8% Point72 Asset Management, L.P. 30 Sep 2025
TSEM TOWER SEMICONDUCTOR LTD Ordinary Shares, par value NIS 15.00 per share 2.6% $206,369,650 -$252,010,688 2,854,352 -55% Point72 Asset Management, L.P. 30 Sep 2025
AMLX Amylyx Pharmaceuticals, Inc. Common Stock, par value $0.0001 per share 2.6% $38,074,233 -$26,039,432 2,801,636 -41% Point72 Asset Management, L.P. 30 Sep 2025
ENTX Entera Bio Ltd. Ordinary shares, par value NIS 0.0000769 per share 2.6% $2,153,271 -$2,763,568 1,183,116 -56% Point72 Asset Management, L.P. 30 Sep 2025
CTMX CytomX Therapeutics, Inc. Common Stock, par value $0.00001 per share 2.5% $12,978,754 -$12,811,193 4,068,575 -50% Point72 Asset Management, L.P. 30 Sep 2025
VNET VNET Group, Inc. Class A Ordinary Shares, par value $0.00001 per share 2.4% $295,901,634 -$314,996,162 38,180,856 -52% Steven A. Cohen 30 Jun 2025
RPD Rapid7, Inc. Common Stock, par value $0.01 per share 2.4% $34,974,135 1,502,971 Point72 Asset Management, L.P. 31 Dec 2024
OLMA Olema Pharmaceuticals, Inc. Common Stock, par value $0.0001 per share 2.3% $4,909,701 1,543,931 Point72 Asset Management, L.P. 31 Mar 2025
ARRY Array Technologies, Inc. Common Stock, par value $0.001 per share 2% $13,012,822 -$19,422,763 3,054,653 -60% Point72 Asset Management, L.P. 31 Mar 2025
DYN Dyne Therapeutics, Inc. Common Stock, par value $0.0001 per share 1.5% $12,603,532 -$26,630,775 1,669,342 -68% Point72 Asset Management, L.P. 31 Mar 2025
LITE Lumentum Holdings Inc. Common Stock, par value $0.001 per share 1.3% $110,518,907 -$408,208,441 895,470 -79% Point72 Asset Management, L.P. 30 Jun 2025
SPHR Sphere Entertainment Co. Class A Common Stock, par value $0.01 per share 0.8% $13,881,584 -$81,500,570 223,464 -85% Point72 Asset Management, L.P. 30 Sep 2025
RGLS Regulus Therapeutics Inc. Common Stock, par value $0.001 per share 0.3% $1,897,906 -$28,982,448 241,157 -94% Point72 Asset Management, L.P. 30 Jun 2025
ANNX Annexon, Inc. Common Stock, par value $0.001 per share 0.1% $131,693 95,430 Point72 Asset Management, L.P. 31 Mar 2025
WHWK Whitehawk Therapeutics, Inc. Common Stock, par value $0.0001 per share 0% $8,394 -$2,417,620 5,087 -100% Point72 Asset Management, L.P. 31 Mar 2025
KALA KALA BIO, Inc. Common Stock, par value $0.001 per share 0% $407 -$742,054 257 -100% Point72 Asset Management, L.P. 30 Sep 2025
SYRS Syros Pharmaceuticals, Inc. Common Stock, par value $0.001 per share 0% $9.92 496 Point72 Asset Management, L.P. 31 Dec 2024
IKT Inhibikase Therapeutics, Inc. Common Stock, par value $0.001 per share 0% $0 0 Point72 Asset Management, L.P. 31 Dec 2024
JOYY JOYY Inc. Class A Common Shares, par value US$0.00001 per share 0% $0 0 Point72 Asset Management, L.P. 31 Mar 2025
TSBX Turnstone Biologics Corp. Common Stock, par value $0.001 per share 0% $0 0 Point72 Asset Management, L.P. 30 Sep 2025
SHLS Shoals Technologies Group, Inc. Class A Common Stock, par value $0.00001 per share 0% $0 -$61,741,014 0 -100% Point72 Asset Management, L.P. 30 Jun 2025
CDMO Avid Bioservices, Inc. Common Stock, par value $0.001 per share 0% $0 0 Point72 Asset Management, L.P. 31 Dec 2024
SGMT Sagimet Biosciences Inc. Series A Common Stock, par value $0.0001 per share 0% $0 -$13,268,881 0 -100% Point72 Asset Management, L.P. 30 Jun 2025

Schedules 13D/G Reported by Point72 Asset Management, L.P.:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Filing Date
* An asterisk sign (*) next to the price indicates that the price is likely invalid.